This brand name is authorized in Ecuador, Mexico
The drug DORIXINA contains one active pharmaceutical ingredient (API):
|
1
Lysine
UNII 06PW4M190R - CLONIXIN LYSINE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B05XB03 | Lysine | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05X I.V. solution additives → B05XB Amino acids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 22.367-1-05-05, 5298-MEE-0720 |
| Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 048M81, 325M81 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
